FDA — authorised 22 April 2024
- Application: BLA761336
- Marketing authorisation holder: ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
- Local brand name: ANKTIVA
- Indication: SOLUTION — INTRAVESICAL
- Status: approved
🇺🇸 ANKTIVA in United States
FDA authorised ANKTIVA on 22 April 2024
Marketing authorisations
FDA
- Status: approved
ANKTIVA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is ANKTIVA approved in United States?
Yes. FDA authorised it on 22 April 2024; FDA has authorised it.
Who is the marketing authorisation holder for ANKTIVA in United States?
ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU holds the US marketing authorisation.